Sign in

Andrew Azman

@andrewazman.bsky.social
488 followers 16 following 1 posts

Infectious Disease Epidemiologist, Professor, University of Geneva

PostsRepliesMedia
Reposted by Andrew Azman
Geneva Disease Dynamics group @gddynamics.bsky.social · 16/09/2026
Our work on false-positive mpox results in high-transmission settings is out @thelancetinfdis.bsky.social. Of 2,724 suspected cases in DR Congo, ~35% of qPCR positives (Ct<40) were estimated to be environmentally derived. A Ct cutoff of <34 reduced this to ~5%, with only marginal sensitivity losses
121
Reposted by Andrew Azman
epicentre-msf.bsky.social @epicentre-msf.bsky.social · 30/07/2026
Could existing Ebola vaccines help respond to the current Bundibugyo outbreak in the DRC? A new @thelancetinfdis.bsky.social commentary suggests that deploying Ervebo in high-risk groups could provide protection while generating crucial evidence for future outbreaks www.thelancet.com/journals/lan...
thelancet.com
Reconsidering the rVSVΔG-ZEBOV-GP vaccine during the 2026 Bundibugyo virus outbreak
The ongoing 2026 Bundibugyo virus disease (BVD) public health emergency of international concern in DR Congo and Uganda has exposed gaps in preparedness for non-zairense orthoebolaviruses. With BVD va...
011
Reposted by Andrew Azman
Geneva Disease Dynamics group @gddynamics.bsky.social · 07/08/2026
GDD is honored to host SMIDDY's 10th edition, on Thu, Nov 5, 2026 at Campus Biotech, Geneva. Keynotes by Prof. Rachel Lowe (BSC) & Prof. Justin Lessler (UNC Chapel Hill). Seats limited, abstract deadline Sept 4, 2026. Info: sniddy.ch/smiddy_2026/
lnkd.in
LinkedIn
This link will take you to a page that’s not on LinkedIn
101
Reposted by Andrew Azman
epicentre-msf.bsky.social @epicentre-msf.bsky.social · 10/01/2025
📢 Our study carried out after the first hepatitis E vaccination campaign in Bentiu, South Sudan shows that the two-dose regimen is effective, supporting its use in similar contexts. #HepatitisE #vaccineswork 💉 @andrewazman.bsky.social www.thelancet.com/journals/lan...
thelancet.com
The effectiveness of two doses of recombinant hepatitis E vaccine in response to an outbreak in Bentiu, South Sudan: a case–control and bias indicator study
Despite the small sample size, our estimates provide evidence of effectiveness of a two-dose regimen against HEV genotype 1 during a protracted outbreak, supporting its use in similar contexts.
012